Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the long-term safety and efficacy of subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or pemphigus foliaceus was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus Foliaceus
• Pemphigus Vulgaris

Drugs mentioned

• Vyvgart (efgartigimod) (efgartigimod)

Snippet

Sponsor: argenx | Conditions: Pemphigus Vulgaris, Pemphigus Foliaceus | Phase 3 | Status: TERMINATED | Results posted: 2025-03-30